Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 9
1995 23
1996 38
1997 56
1998 68
1999 97
2000 152
2001 182
2002 201
2003 315
2004 281
2005 177
2006 248
2007 206
2008 233
2009 268
2010 255
2011 290
2012 318
2013 327
2014 308
2015 307
2016 251
2017 268
2018 222
2019 142
2020 12
Text availability
Article attribute
Article type
Publication date

Search Results

4,701 results
Results by year
Filters applied: . Clear all
Page 1
Aryl hydrocarbon receptor ligands in cancer: friend and foe.
Murray IA, Patterson AD, Perdew GH. Murray IA, et al. Nat Rev Cancer. 2014 Dec;14(12):801-14. doi: 10.1038/nrc3846. Nat Rev Cancer. 2014. PMID: 25568920 Free PMC article. Review.
PPARs and nonalcoholic fatty liver disease.
Liss KH, Finck BN. Liss KH, et al. Biochimie. 2017 May;136:65-74. doi: 10.1016/j.biochi.2016.11.009. Epub 2016 Dec 2. Biochimie. 2017. PMID: 27916647 Free PMC article. Review.
Transcription factors as therapeutic targets in CNS disorders.
Kane MJ, Citron BA. Kane MJ, et al. Recent Pat CNS Drug Discov. 2009 Nov;4(3):190-9. doi: 10.2174/157488909789104820. Recent Pat CNS Drug Discov. 2009. PMID: 19891598 Review.
An update on PPAR activation by cannabinoids.
O'Sullivan SE. O'Sullivan SE. Br J Pharmacol. 2016 Jun;173(12):1899-910. doi: 10.1111/bph.13497. Epub 2016 May 19. Br J Pharmacol. 2016. PMID: 27077495 Free PMC article. Review.
Natural Nrf2 activators in diabetes.
Jiménez-Osorio AS, González-Reyes S, Pedraza-Chaverri J. Jiménez-Osorio AS, et al. Clin Chim Acta. 2015 Aug 25;448:182-92. doi: 10.1016/j.cca.2015.07.009. Epub 2015 Jul 9. Clin Chim Acta. 2015. PMID: 26165427 Review.
Retinoid X Receptor Selective Agonists and their Synthetic Methods.
Wagner CE, Jurutka PW, Marshall PA, Heck MC. Wagner CE, et al. Curr Top Med Chem. 2017;17(6):742-767. doi: 10.2174/1568026616666160617091559. Curr Top Med Chem. 2017. PMID: 27320333 Review.
Safety, pharmacodynamics, and potential benefit of omaveloxolone in Friedreich ataxia.
Lynch DR, Farmer J, Hauser L, Blair IA, Wang QQ, Mesaros C, Snyder N, Boesch S, Chin M, Delatycki MB, Giunti P, Goldsberry A, Hoyle C, McBride MG, Nachbauer W, O'Grady M, Perlman S, Subramony SH, Wilmot GR, Zesiewicz T, Meyer C. Lynch DR, et al. Ann Clin Transl Neurol. 2018 Nov 10;6(1):15-26. doi: 10.1002/acn3.660. eCollection 2019 Jan. Ann Clin Transl Neurol. 2018. PMID: 30656180 Free PMC article. Clinical Trial.
4,701 results
Jump to page
Feedback